Optimization of Biophotonics and Optomechanics for Frequency Domain Tissue Fluorescence Measurements by Zou, Luwei






A thesis submitted in partial fulfillment 
of the requirements of the degree of 
Master of Science in Engineering 
(Mechanical Engineering) 











Master’s Thesis Committee: 
 
Assistant Professor Joe Fujiou Lo, Chair 
Assistant Professor Mathumai Kanapathipillai 






I would like to thank Prof. Joe Fujiou Lo for his support and mentoring of my thesis. I would also 
like to thank Rui Liu for finishing the early ground works that went into this thesis. Moreover, I 
thank the members of Dr. Lo’s Lab for their assistance and friendship throughout my studies in 
University of Michigan at Dearborn: Rui Liu, Mengyang Zhou, Zhengtuo Zhao, Di Hu, Kai Duan, 
Mohammed-Baker Habhab, Tania Ismail and Jessica Hallgath. I would also like to thank University 




Table of Contents 
Acknowledgements .................................................................................................................... ii 
List of Figures ........................................................................................................................... vi 
List of Tables ........................................................................................................................... vii 
List of Abbreviations ............................................................................................................. viii 
Abstract ..................................................................................................................................... ix 
Chapter 1: Overall Introduction ................................................................................................. 1 
Characteristics of Collagen and Tissue Autofluorescence ..................................................... 2 
Time and Frequency Domain Lifetime for Collagen ............................................................. 3 
References .............................................................................................................................. 5 
Chapter 2: Compact, Non-invasive Frequency Domain Lifetime Differentiation of Collagens 
and Elastin .................................................................................................................................. 8 
Introduction ............................................................................................................................ 8 
Collagen and ECM Composition of Ocular Tissue ............................................................ 8 
System Setup ...................................................................................................................... 9 
Method ................................................................................................................................. 10 
FD ECM Detection System Overview ............................................................................. 10 
System Optomechanics ..................................................................................................... 11 
System Calibration ........................................................................................................... 12 
Fluorescence Standard, Purified Protein, and Tissue Sample Preparation ....................... 12 
Frequency Domain Analysis ............................................................................................ 13 
Data Processing ................................................................................................................ 15 
Result and Discussion .......................................................................................................... 16 
System Calibration Results .............................................................................................. 16 
iv 
 
Spectral Domain Alone Cannot Distinguish Collagen Types and Elastin ...................... 18 
Frequency Domain Phase Shift Results ........................................................................... 18 
Frequency Domain Demodulation Results ...................................................................... 19 
Multi-exponential Fitting of Collagen, Elastin, and Tissue Lifetimes ............................ 21 
Performance of FD ECM Detection System ................................................................... 22 
Future Modifications for Complex Tissue ECM Collagens ............................................ 24 
Summary .............................................................................................................................. 25 
References ............................................................................................................................ 26 
Chapter 3 3D Printed Miniaturized Spectral System for Collagen Fluorescence Lifetime 
Measurements ........................................................................................................................................................ 29 
Introduction .......................................................................................................................... 29 
Collagen Spectral Lifetime ............................................................................................... 29 
Optomechanics Rapid Prototyping via Additive Manufacturing ..................................... 30 
System Setup .................................................................................................................... 31 
Method ................................................................................................................................. 32 
Miniaturized Optics .......................................................................................................... 32 
Custom Built Optomechanics ........................................................................................... 34 
Thermal and Mechanical FEA .......................................................................................... 35 
FEA Parameters Investigated ........................................................................................... 36 
Optical Ray Tracing .......................................................................................................... 37 
Frequency Domain Method .............................................................................................. 37 
Electronics and Data Acquisition ..................................................................................... 38 
Result and Discussion .......................................................................................................... 39 
Thermal FEA Results Indicate Negligible Strain ............................................................. 39 
Mechanical FEA Results are Comparable to Other 3D Printings .................................... 40 
Ray Tracing for Optical Optimization .............................................................................. 41 
Frequency Domain Phase Shift Results ............................................................................ 43 
Frequency Domain Demodulation Results ....................................................................... 43 
v 
 
Frequency Domain Lifetime ............................................................................................. 44 
Future Works ........................................................................................................................ 45 
Summary .............................................................................................................................. 47 
References ............................................................................................................................ 48 
Chapter 4 Enabling FLIM for Histology: Facile and Stain-free Tissue Lifetime Imaging ..... 50 
Introduction .......................................................................................................................... 50 
Monitoring Protein Glycation in Diabetes ........................................................................ 50 
Method ................................................................................................................................. 51 
LED Tissue Lifetime Imaging System ............................................................................. 51 
System Characterization ................................................................................................... 53 
Biophotonics Measurements ............................................................................................. 53 
Data Acquisition and Analysis ......................................................................................... 54 
Result and Discussion .......................................................................................................... 54 
Optical Ray Tracing .......................................................................................................... 54 
Etendue and Spot Size Characterization ........................................................................... 55 
Stage Calibration .............................................................................................................. 57 
Biophotonic Model of Diabetic Wound ........................................................................... 58 
Imaging Diabetic Foot Ulcer ............................................................................................ 59 
Future Works ........................................................................................................................ 60 
Summary .............................................................................................................................. 60 
References ............................................................................................................................ 62 
Chapter 5 Conclusion ......................................................................................................................................... 67 
vi 
 
List of Figures 
Figure 1. Fiber Based Frequency Domain Collagen and Elastin Detection System ............... 10 
Figure 2. FD ECM Detection Optomechanics Design  ........................................................... 11  
Figure 3. References Phase and Modulation Ratios  .............................................................. 16 
Figure 4. Fluorescence Spectra of Standards, Proteins, And Complex Tissue 
Autofluorescence  ................................................................................................................... 17 
Figure 5. Phase Shifts Are Consistent with Lifetimes of Fluorescence Standards and Can 
Distinguish ECM Proteins That Comprise Tissues  ............................................................... 19 
Figure 6. Demodulation Results Can Also Distinguish Collagen Proteins That Comprise 
Tissues .................................................................................................................................... 20 
Figure 7. FD ECM Detection System Sensitivity  .................................................................. 23 
Figure 8. Schematics of the 3D Printed Probe for Tissue Collagen Differentiation  .............. 31 
Figure 9. Spectral Lifetime Microoptics System Setup  ......................................................... 33 
Figure 10. 3D Optomechanics System and FEA Parameters  ................................................ 34 
Figure 11. Thermal and Mechanical FEA for Wall Thickness and Materials in 3D Printing  41 
Figure 12. Optical Ray Tracing Simulation of the Excitation Stage  ..................................... 42 
Figure 13. Optical Ray Tracing Simulation of the Emission Stages  ..................................... 43 
Figure 14. Frequency Domain Results for Spectral-Fluorescence Separation of Collagen I/III 
.................................................................................................................................................. 44 
Figure 15. System Schematic  ................................................................................................. 52 
Figure 16. Ray Tracing Modeling  .......................................................................................... 55 
Figure 17. Etendue and Spot Size Characterization  ............................................................... 56 
Figure 18. Data Acquisition Rate and Standard Deviation Versus Buffer Size  .................... 57 
Figure 19. Intrinsic Lifetimes of ECM Proteins and Their Modification by Pentosidine (AGE) 
.................................................................................................................................................. 58 




List of Tables 
Table 1. System Components  ................................................................................................ 12 
Table 2. Single Exponential Fitting for Fluorescence Samples  ............................................. 21  
Table 3. Multi-Exponential Fitting for Protein Samples  ....................................................... 21 
Table 4. Multi-Exponential Fitting for Ocular Tissue Samples  ............................................. 22 
Table 5. Multi-Exponential Fitting for Wound Skin Samples  ............................................... 22 
Table 6. Component List of The System  ............................................................................... 33 
Table 7. Measured Coupling at Different Stages of The Microoptics System  ...................... 35 





List of Abbreviations 
FD Frequency domain 
ECM Extra cellular matrix 
PMT Photomultiplier tube 
DSO Digital storage oscilloscope 
APD Avalanche photodiode 
FAD Flavin adenine dinucleotide 
FITC Fluorescein isothiocyanate 
9CA 9-Anthracenecarboxylic acid 
DC Direct current 
DLP Digital light processing 
CAD Computer-aided design 
FEA Finite element analysis 
PLA Polylactic acid 
ABS Acrylonitrile butadiene styrene 
NA Numerical aperture 
UV Ultraviolet 
FFT Fast Fourier transform 
NADH Nicotinamide adenine dinucleotide 
AGEs Advanced glycation end-products 
FWHM Full width at half max 
CCD Charge-coupled device 
PBS Phosphate-buffered saline 






Collagens and extra cellular matrix (ECM) proteins play important roles in the structural 
composition of tissues, and their modifications are implicated in diseases including cancer 
metastasis, tissue fibrosis, diabetic ulcers. Current tissue collagen analyses are based on 
destructive histological methods, whereas the ECM proteins’ intrinsic autofluorescences can 
provide a label-free detection and imaging to differentiate tissue compositions, modifications, 
and disease states. Fluorescence lifetime spectroscopy has been demonstrated as a key 
technique to distinguish ECM proteins in tissue. However, the large, expensive, and often 
operationally challenging instrumentation required to measure fluorescent lifetimes from 
tissues prevents the technique from gaining traction in biomedical applications. 
 
To this end, this thesis represents three major efforts to address this roadblock in tissue lifetime 
instrumentation by 1) demonstrate a facile fluorescence lifetime technique via frequency 
domain analysis, 2) realizing a hand-held multispectral lifetime probe for point detection on 
the skin, 3) realizing a low-cost, low complexity LED based imaging system to enable FLIM 
(fluorescence lifetime imaging microscopy) for histology without daunting instrumentation. 
 
In the first effort, the frequency domain (FD) fluorescence lifetime technique was demonstrated 
for the differentiation of collagens I/III and elastin, three major biophotonic components in 
wound tissues that undergo change during healing. In the second effort, a compact multispectral 
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system demonstrated the FD lifetime’s utility as a point-of-care device, and added additional 
wavelength-specific lifetime spectroscopy to further improve differentiation. The third effort 
expands the FD technique to an imaging modality, by leveraging LED scanning optomechanics 
to create histological images of tissues without labeling. Additionally, the scanning of a 
diabetic ulcer showed evidence that the technique can provide quantitative information on 
disease modification of the tissue that current immunohistochemical methods are ill-equipped 
to provide. By providing a quantitative, more nuance model of tissue biophotonics while using 
low-cost, low complexity FD instrumentation, the works in this thesis hopes to increase 
accessibility and popularity of label-free ECM lifetime spectroscopy for a number of 
biomedical and clinical applications. 
 
Keywords: 
Optomechanics, autofluorescence, frequency domain, 3D printing, collagen, elastin, wound 
healing, diabetes, advanced glycation end products, LED, FLIM  
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Chapter 1 Overall Introduction 
 
Collagen composition in the tissue’s extra cellular matrix (ECM) varies during many processes 
such as cancer metastasis, wound healing, fibrosis, and aging. In wound healing, specifically, 
ECM is disrupted by the act of wounding and injury. In addition, the proliferation and 
remodeling phase of wound healing involves a change from immature type III collagen to the 
stronger type I collagen [1-4]. Monitoring collagen transition during these processes, then, can 
provide important information about wound maturity and strength. Current techniques to 
visualize and quantify changes in tissue collagen types rely on immunohistochemistry and 
polarized picrosirius staining under the microscope [5-8]. Novel methods such as laser-induced 
fluorescence and multiphoton excitation are becoming popular as label-free detection 
techniques, which have already been applied to ocular, skin, and liver tissue microscopies [9-
17], in addition to our work on differentiating collagen types via fluorescence lifetimes [18].  
 
Collagen and ECM Composition of Skin Wounds Tissue 
In skin wounds, collagen remodeling occurring underneath a closing wound cannot be easily 
assessed by visual monitoring. The primary structural component of normal dermis is mostly 
collagen, with elastin, glycoproteins, and glycosaminoglycans also present. During the 
proliferation phase, fibroblasts proliferate in the wound and produce ECM, especially 
collagens, to replace the provisional matrix formed in homeostasis/inflammatory stage of the 
earlier wound healing process to establish scar tissue [4]. Normal skin and wounds that have 
undergone collagen remodeling contain more mature cross-linked collagen I fibers, while 
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immature wounds contain more parallel collagen III fibers [5, 6].  Elastin is another major 
molecule of ECM produced by fibroblasts and smooth muscle cells, which provide resilience 
to the skin and other tissues. It is abnormally expressed during skin wound healing which 
partially contributes to the impaired breaking strength of scars compared with unwounded 
skin [7]. Restoration of normal ECM architecture is necessary for skin wounds to gain the 
tensile strength that is required to maintain tissue integrity [1]. Full thickness murine wounds 
have been used as important models to study wound healing, including collagen remodeling 
processes. 
 
Characteristics of Collagen and Tissue Autofluorescence  
Autofluorescence from collagen (i.e. without staining) is commonly observed in cell and tissue 
microscopy. The major collagen fluorophores are lysine derived pyridinium, tyrosine, and 
phenylalanine groups [8-11], which can be affected by crosslinking, glycation, and their 
compositions in different types of collagens [12-14]. Collagen autofluorescence, in 
combination with other endogenous fluorophores, can provide differentiation between normal 
and cancerous tissues [15, 16], promising tumor demarcation in minimally invasive surgeries 
[17, 18]. Moreover, collagen fiber orientation and crystallinity enable second harmonic 
generation (SHG) using laser induced autofluorescence [19-23]. Both multiphoton collagen 
autofluorescence and SHG have been adapted for monitoring skin aging [24, 25] and 
investigating ocular pathology [26-30]. Despite the ability to detect endogenous 
fluorophores—e.g. NADH+, elastin, and collagen—no differentiation of collagen types using 
SHG and multiphoton microscopy has been demonstrated. This is because very little 
differences exist in the spectral domain of collagen types, e.g. I versus III. However, 
autofluorescences from different collagen types evidently have strong differences in the time 
domain [31, 32]—their lifetimes are significantly different and sensitive to the crosslinking and 
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glycation, as mentioned earlier. Therefore, fluorescence lifetime spectroscopy, either in the 
time-domain or frequency domain, can provide non-invasive differentiation of collagen types 
in tissue. 
 
Time and frequency domain lifetime for collagen 
Collagen and elastin autofluorescence, and fluorescence in general, can be modeled as a linear, 
time-invariant system with a characteristic impulse response function specific to a particular 
fluorophore [33-35]. Therefore, the input (excitation) and output (emission) of such a system 
can be considered in time and frequency domains. In the time domain, the input excitation is 
convolved with the impulse response to yield the emission intensity over time. This time 
domain method has been demonstrated with sub-nanosecond pulsed lasers and fast 
photomultiplier tube (PMT) detectors to reconstruct collagen fluorescence impulse response 
decays, with associated lifetime constants [36-39]. While the time domain method obtains more 
information over shorter pulses, the cost of the pulsed lasers, triggering electronics, and PMT 
detectors, in addition to the complexity of the system, prevent its wider use in biomedical 
applications. On the other hand, frequency domain method preserves the modulation frequency 
of the sinusoid, while changing the modulation amplitude and phase as a function of the 
specific fluorophore’s impulse response decay. This is analogous to a linear time-invariant 
system encountered in electrical circuits. Frequency domain technique is a lower complexity, 
cost-effective alternative for monitoring biological tissues compared to time domain method 
[17, 18]. Optimum modulation frequencies for tissue structural proteins like collagens and 
elastin range from 10-100 MHz [19]. This lowers requirements for the LED driver electronics, 
photodetector amplifier responses, and signal digitization and recording speeds [20, 21]. A 
single, portable USB multi-channel digital storage oscilloscope (DSO) can perform the 
acquisitions for both the excitation and emissions waveforms. Using the phase ∆ϕ and 
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modulation m from oscilloscope measurements, two lifetimes can be calculated and combined 
via multi-exponential models, at particular wavelengths, to find characteristic lifetimes of a 
sample. 
𝜏" = 𝜔%& tan Δ𝜙             (1) 
and 
𝜏, = 𝜔%& 𝑚%. − 1 &/.           (2) 
In this study, the characteristic lifetimes of collagens at three wavelength bands were quantified 
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Chapter 2 Compact, Non-invasive Frequency 
Domain Lifetime Differentiation of Collagens and 
Elastin in Wound and Ocular Tissue 
 
Introduction 
Collagen and ECM Composition of Ocular Tissue 
In the eye, the type and orientation of collagen fibers vary by region and are closely related to 
the eye’s functions [2, 4, 5]. For example, in the peripapillary region where the optic nerve 
exits the sclera, there is a predominant circumferential fiber alignment [6] that likely functions 
to control deformation and stress in the optic nerve head tissues. Similar to skin and other 
connective tissues, sclera is primarily composed of a matrix containing collagens, elastin [7], 
and proteoglycans [8]. The result is a tissue having strength and viscoelastic properties that 
help to protect the eye from severe loads, and also from brief elevations in intraocular pressure 
due to eye movements and other events such as rubbing. In the cornea, the lamellae are 
composed of collagen fibrils of uniform diameter running parallel to one another; however, in 
the sclera the collagen fibrils have varying diameter with an irregular branching pattern [9, 10]. 
Human eye tissue contains about 90% type I collagen and less than 5% type III collagen [2]. 
Levels of type III collagen in the bovine cornea average less than 1% in animals older than 3 
months [11, 12]. Disorders in the ocular structure play a role in diseases such as glaucoma[13, 
14] which manifests as damage to the tissues of the optic nerve head, and the corneal thinning 
disease keratoconus [15]. Structural problems of the sclera have also been implicated in myopia 
[16]. Abnormal elastin has been found in the lamina cribrosa tissue, which bridges the opening 
in the sclera at the optic nerve head, of glaucomatous eyes [16]. A noninvasive assay of tissue 
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would aid research into eye disorders such as these as well, as skin wounds discussed above, 
and could eventually be used as a diagnostic tool. 
 
System setup 
In this study, a general method is developed to detect and differentiate ECM proteins. Here, 
detections were demonstrated with type I collagen, type III collagen and elastin in the context 
of their measurements in skin wounds and ocular tissues [1-3]. The method uses a low cost, 
low complexity light emitting diode (LED) system to realize both non-invasive detection and 
specific discrimination of collagen and elastin variations in tissue. Modulated LED excitation 
was applied to frequency domain (FD) fluorescence lifetime spectroscopy to determine tissue 
autofluorescence lifetimes, Figure 1.  It is shown that fluorescence lifetimes from collagen 
type I, collagen type III and elastin can be clearly distinguished. The extension of the method 
to detect other collagen types and ECM components is also discussed. Due to the low cost of 
LED and photodiode components, low complexity of the fiber optic probe, and the possibility 
of integrating phase and demodulation analyses on an integrated circuit, the developed 
technique is well suited to portable applications. Applications in implantable sensors, field 
diagnostics, and clinical monitoring can benefit from this technique to measure collagen and 









      
D) 
 
Figure 1. Fiber based frequency domain collagen and elastin detection system. A) 
Frequency domain fluorescence lifetime is based on the phase shift delay and amplitude 
demodulation of the fluorescence emission when a sample is excited by a modulated light 
source. B) The components of the systems are compact and cost-effective. This system can be 
applied to C) non-invasive probing of ocular tissue, and D) non-contact monitoring of wound 
healing. (Note that ocular and skin tissues were cut into samples and measured in this study.) 
 
Method 
FD ECM Detection System Overview 
The system is composed of the following components: A modulated 365 nm wavelength LED 
(DC3100-365, Thorlabs, NJ) was used as the light source along with a 375 nm low-pass filter. 
This sinusoid modulated excitation light was carried by a 7 around 1 UV-resistant fiber probe 
(Stellarnet, FL) to illuminate the sample at frequencies from 10 MHz to 60 MHz. The emission 
and the reflected/scattered light from the sample were collected by the 7 fibers and the 
reflected/scattered light was then filtered by two 400 nm high pass filters. An avalanche 
photodiode (APD-110C, Thorlabs, NJ) picked up the filtered emission intensity and compared 
its modulation with the LED source on an oscilloscope, Figure 2. Because of the availability 
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of modulated LED, fast avalanche photodiode, and sub 100 MHz oscilloscope at affordable 
costs, the FD collagen system in this study does not require extra signal generator or heterodyne 
electronics [23, 24], and has a generally low overall system cost. 
 
System Optomechanics 
To couple the light from the LED, a plano-convex lens was used to collimate the light through 
the 375 nm low pass filter and focused by a second plano-convex lens onto the fiber probe. The 
fiber probe configuration has one illumination core in the center and 7 surrounding collection 
cores. This gives higher collection efficiency with smaller detection spot provided by the single 
illumination core. Similar to the LED coupling, detector coupling was achieved by collimating 
the collection fiber output through high pass filters. Then the signal was focused on the APD 
with a pair of plano-convex lenses (as shown in Figure 2). Moreover, the high pass filters, as 
well as neutral density filters, were mounted on a filter wheel to enable them to be moved in 
and out of the light path during normal and calibration operations. The components details and 





Figure 2. FD ECM detection optomechanics design. At the modulated LED light source, a 
pair of plano-convex lenses (ϕ25.4, f=25.4) help to couple light through an excitation filter 
(275-375 nm bandpass) into a 600 µm fiber. This excitation is illuminated on a fluorescence 
sample, and the emission is collected by seven 600 µm fibers into the detector coupling 
block. In the block, a plano-convex lens (ϕ12.7, f=20.0) collimates the emission intensity 
through a pair of 400 nm high pass filters, which can also be replaced by either a pin hole or a 
neutral density filter during calibration procedures. The filtered emission is then focused by 
an aspheric lens (ϕ25.0, f=20.0) onto a fast, avalanche photodiode. The efficiencies of the 
system can be interpreted by the optical power measured at various positions, as well as 
typical sample fluorescence from FAD and Collagen I. 
 
Table 1. System Components 
Component Relevant Spec Price 
Thorlabs Modulated LED Source 700 mA, 10-90 MHz sinusoid $2510 
1” Lens tube components SM1 lens tube, SM1 collimator $450 
SM1 optics 1” lens and lens tubes $200 
Colored Glass Bandpass 275-375 nm $86 
Stellarnet 7 around 1 probe 600 µm, solarization resistant $600 
Manual filter wheel 6 positions, 1” optics $145 
Thorlabs Long pass FEL0400  400 nm $73 (2) 
Thorlabs APD120A2 Photodiode DC-50 MHz (3dB), 2.5e6 V/W $1070 
Rigol DS1000B Oscilloscope 200 MHz, 2 GSa/s $945 
 
System Calibration 
Phase shift and modulation depth ratio of the system were calibrated for comparisons between 
solid and liquid sample measurements. During these calibration measurements, the emission 
filters were switched out and replaced with neutral density filters or pin holes to further reduce 
intensity. For the reference phase angles, reflected/scattered light was measured at 10 to 60 
MHz from frosted glass, water, and ethanol media to compare with measurements from 
powder/fiber form, aqueous solutions and ethanol solutions, respectively. For the reference 
modulation depth ratios, the LED waveform’s b/a ratios were measured for the frosted glass, 
water, and ethanol solutions, to parallel those measured for phase references.  
 
Fluorescence Standard, Purified Protein, and Tissue Sample Preparation 
For comparison to known lifetime standards, three fluorescence standards were measured: 
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flavin adenine dinucleotide (FAD), fluorescein isothiocyanate (FITC), and 9-
Anthracenecarboxylic acid (9CA). 0.1 mM FAD was prepared in water while 0.1 mM FITC 
and 9CA were prepared in ethanol. FAD, fluorescein, and 9CA have lifetimes of 2.57, 3.94, 
and 11.75 ns, covering the range of lifetimes expected form the purified ECM proteins. Then, 
three purified ECM proteins were measured—collagen I, collagen III, and elastin—to represent 
important ECM components in ocular and skin tissues. Purified proteins were measured in 
solid powder or fiber forms. Finally, lifetime measurements were conducted in bovine sclera 
and cornea tissues, and murine normal and wound skin tissues (14 days post-wounding).  
In this study, bovine tissue is used because it is plentiful and of similar consistency to human 
eye tissue and is often used as a precursor to experiments using cadaveric or surgical specimens 
of human origin [12, 25]. Bovine eyes were obtained from a local slaughterhouse and tested 
within 48 hours of the animal’s death. Scleral and corneal tissues were dissected from the 
surrounding fat and extraocular muscles, then separated from the internal contents of the eye.  
The scleral and corneal tissues were then cut into 5 mm squares for measurement. 
Measurements were done normal to the external surface of the tissue samples.  
BALB/C mice were used in the skin wound model. Murine experimental procedures followed 
the University of Illinois guidelines for the humane treatment of animals and were approved 
by the University of Illinois Institutional Animal Care and Use Committee. Wound models 
were created using 5 mm punch biopsies on day 0 and collected on day 14 post-wounding with 
8 mm punch biopsies. Immediately after biopsy sampling, skin and wound tissues were 
measured normal to the external surface of the tissues.  
 
Frequency Domain Analysis 
During data acquisition, the raw emission signals were averaged 128 times in the oscilloscope 
to reduce effects of noise, then the averaged signals were imported into MATLAB (MathWorks, 
14 
 
MA) and fitted to sine functions. The least-square method was employed to fit the raw signals 
to a sine function with known frequencies. 
𝑦 = 𝑎 + 𝑏 sin(𝜔𝑥 − 𝜙) , or  𝑦 = 𝐴 + 𝐵 sin(𝜔𝑥 − 𝜙)  (1) 
Where ω is known when the sample is excited under the LED light with a certain frequency, x 
is the time axle, and y is the raw voltage data. The parameters phase ϕ, amplitude b, offset a 
for the excitation and phase ϕ, amplitude B, offset A for the emission waveforms (Figure 1A) 
are readily extracted from the curve fitting. However, there were noticeable DC offsets in the 
raw signals depending on measurement frequencies and oscilloscope settings. Therefore, DC 
offsets from dark readings (LED turned off) at specific measurement conditions were 
subtracted from the raw data before fitting and data processing. This process allowed more 
accurate calculations of the phase shift angles and modulation depths, without peak 
uncertainties, amplitude drifts, and waveform asymmetries from one part of the raw data to 
another, leading to better lifetime measurements. 
After getting the phase angles and modulation depth ratios between 10 MHz to 60 MHz, the 
data was fitted to a multi-exponential model as described in [26], where the fluorescence 
impulse response function is assumed to be: 
𝐼 𝑡 = 𝛼@e%B/CDE@F&   (2) 
Where 𝛼@ is the lifetime fraction of each component 𝜏@ and 𝛼@ = 1. Thus	𝐼 𝑡 	appears as 
a decay curve containing multiple exponents represented in the sample. The calculated phase 
shift angle𝜙HI and modulation 𝑚HI can then be obtained from the sine 𝑁I and cosine 𝐷I 








  (4) 
Where their numerical values can be calculated by: 
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@F&   (6) 
Where 𝐽 = 𝛼@𝜏@. 
Thus, the phase shift angle 𝜙HI and modulation 𝑚HI can be described by: 
𝜙HI = arctan 𝑁I/𝐷I   (7) 
𝑚HI = 𝑁I. + 𝐷I. &/.  (8) 
An error-weighted 𝜒.  sum of the squares of the deviations between the measured and 
calculated values is minimized to find the best fitting of multi-exponential model. 
𝜒. = &
]^
X 𝜙I − 𝜙HI .I +
&
]_X
𝑚I −𝑚HI .I  (9) 
Where 𝜎"  and 𝜎,  are the typical uncertainties in the phase and modulation data, 
respectively. Respective standard deviations from their measurements were used to represent 
these uncertainties. A single exponential model was used for fluorescence standard FAD, 
fluorescein, and 9CA, to be consistent with other reported studies [58, 64, 69]. A two-
exponential model was used for protein and tissue samples, where fractional 𝛼&, 𝛼., and their 
respective 𝜏& and 𝜏.were calculated by minimizing the 𝜒.	function describing deviations of 
their 𝜙I and 𝑚I values.  
 
Data Processing 
The LED trigger and APD detector signals were acquired using a 200 MHz oscilloscope (Rigol 
DS1000B). The data was then loaded into Matlab (Mathworks) for analysis. The curve fitting 
module was used to fit a sinusoid using the data, at pre-defined frequencies corresponding to 
the LED excitation, e.g. 10, 20 MHz, etc. Curve fitting was chosen over Fourier Transform due 
to its simple implementation in Matlab, where the amplitude, DC offset, and phase shift can be 
directly extracted, without ambiguity. No obvious processing time penalties were observed 
16 
 
using this method. Future implementation of Fourier Transform, however, can be beneficial in 
an embedded data processing unit. After extraction of the phase and modulation parameters, 
they were implemented into a minimization function to fit into the appropriate single/multi-
exponential model.  
 
Result and Discussion 
To characterize the FD ECM detection system, the calibration results and fluorescence spectra 
of each standard, protein, and tissue samples were presented. Then, the FD phase shift and 
demodulation results were presented. Next, the single and multi-exponential fitted lifetimes 
were summarized in Tabulated form. Finally, the relationship between temporal resolution and 
sample detectivity was characterized to describe the sensitivity of the FD system. 
 
System Calibration Results 
The phase angles of mirror/water/ethanol references were fairly close to each other, Figure 3A. 
As with phase references, modulation references did not change significantly among all 





Figure 3. References phase and modulation ratios. A) Phase delays versus frequency of 
LED modulation. B) Modulation depth ratios versus frequency of LED modulation. 
Measurements were made using mirror/water/ethanol references to represent the solid, aqueous, 
and ethanol solvated samples. Error bar denotes standard deviation, n=3 
 



















































Spectral Domain Alone Cannot Distinguish Collagen Types and Elastin 
Spectral data showed that 9CA peaked at 450 nm, fluorescein at 520 nm, and FAD at 530 nm, 
Figure 4. Protein spectra generally overlapped for collagen I/III and elastin, but showed 
significant intensity differences above 450 nm. This spectral overlap, combined with other 
present chromophores like hemoglobin, makes tissue reflectance complicated and difficult to 
interpret. In the FD collagen system described in this manuscript, lifetime measurements were 











Figure 4. Fluorescence spectra of standards, proteins, and complex tissue 
autofluorescence. A) Emission spectra of standards with LED excitation spectra overlaid. B) 
Emission spectra of purified proteins samples. Emission spectra of C) ocular tissues samples 
and D) skin wound samples. Tissue samples have significant difference in the intensity above 
450 nm that is complicated by multiple protein compositions. Standards were in 0.1mM 
concentration in their respective solvents; proteins in powder/fiber forms; and tissues cut into 
samples as described in the sample preparation section. 
 

























































































Frequency Domain Phase Shift Results 
Phase shifts of the tested samples shown in Figure 5 were consistent with lifetimes of 
fluorescence standards and distinguished ECM proteins that comprise tissues. As seen in the 
figure, the phase shift angle rose with frequency as expected, following an inverse tangent 
profile consistent with equation (7). In general, larger phase shift translates to longer lifetime 
at a specific frequency. For the fluorescence standards, the phase shifts increased from FAD, 
fluorescein, to 9CA, in that order, Figure 5A. For the proteins, collagen I consistently measured 
smaller phase shifts than collagen III at all frequencies, while elastin measured larger phase 
shifts than the collagen samples, Figure 5B. For the bovine ocular tissues, the scleral tissue 
measured much larger phase shifts compared to corneal tissue, Figure 5C. The cornea is critical 
to the optical functions of the eye’s lens and its transparency is the result of uniform diameter 
and arrangement of its collagen fibers [28, 29], whose crosslinking could be the cause of the 
smaller phase shift measurements. For the murine wound tissue, larger phase shifts were 
measured compared to normal skin tissue, indicative of longer lifetime components, Figure 5D. 
Compared to the collagen measurements, this difference may be due to the relatively greater 
amount of collagen III (larger phase shift) in the healing wound compared to normal skin [1].  
It should be noted that multiple ECM proteins are present in the tissue samples, and collagen 
itself has multiple lifetime components. The multi-exponential decay model, described later, 
provided better fitting to extract lifetime information from these tissues. Additionally, the phase 
shift results showed that frequency band of 40-50 MHz has optimal separation for the protein 
and tissue samples, especially for skin wounds, where data from 10, 20, and 50 MHz overlaps 











Figure 5. Phase shifts are consistent with lifetimes of fluorescence standards and can 
distinguish ECM proteins that comprise tissues. A) Fluorescence standards showed 
increasing phase shift between FAD, fluorescein, and 9CA, as expected by the order of their 
increasing lifetimes. B) Phase shift between type I and III collagen are distinct, and type III can 
be separated from elastin C) Ocular cornea tissues have smaller phase shift than sclera tissue, 
while D) wound tissues have larger shift compared to normal skin tissue. Error bars denote 
standard deviations, n=3. 
 
Frequency Domain Demodulation Results 
Modulation depth ratios of the tested samples indicated that FD demodulation can distinguish 
collagen proteins that comprise tissues, Figure 6. The modulation depth ratios were seen to 
drop with frequency as expected, following a decay profile consistent with equation (8). At a 
particular frequency, deeper demodulation generally translates to longer lifetime. Modulation 
depth ratios from the standards followed that of the phase shift results, with FAD, fluorescein, 
and 9CA in the order of increasing lifetimes, Figure 6A. Again, collagen I versus III measured 
distinct modulation depth ratios, both shallower than elastin’s values, Figure 6B. Ocular tissue 
demodulation also agreed with the phase results, with sclera having deeper demodulation and 
































































































thus longer lifetime than cornea tissue, Figure 6C. The murine wound also exhibited deeper 
demodulation compared to normal skin tissue, Figure 6D, consistent with the aforementioned 










Figure 6. Demodulation results can also distinguish collagen proteins that comprise 
tissues. A) Fluorescence standards showed deeper demodulations between FAD, fluorescein, 
and 9CA, as expected in the order of their increasing lifetimes. B) Modulation depth ratios 
between type I and III collagen were distinct, and type III could be separated from elastin. C) 
Ocular cornea tissue had shallower apparent demodulation than sclera tissue, while wound 
tissue had marginally deeper demodulation compared to normal skin tissue. Error bars denote 
standard deviations, n=3. 
 
Furthermore, the demodulation results also showed that the frequency band of 40-50 MHz has 
adequate separation for all samples. In the following section on the multi-exponential model, 
both the phase and demodulation results were combined in a minimizing function in order to 
calculate the combined lifetimes. 
 














































































Multi-exponential Fitting of Collagen, Elastin, and Tissue Lifetimes 
The phase shifts and modulation depth ratios were fitted into single or multi-exponential decay 
models, weighted with their respective standard deviations, by minimizing equation (9). The 
fitted lifetimes are shown in Tables 2-5. A single exponential model was used to fit for the 
fluorescent standards. The fitting showed results of 2.57, 3.94, and 11.75 ns for FAD, FITC, 
and 9CA, respectively, which are comparable to results in [21, 22, 27]. Protein samples were 
fitted to a two-exponential model, with a longer lifetime component and a shorter one around 
1 ns, consistent with reported values [19, 20, 27]. Collagen III’s average lifetime was measured 
at 5.01 ns, distinct from and longer than the lifetime of collagen I, 3.95 ns, p=0.001. Other 
reports have also found longer lifetimes for collagen III compared to I [17, 18]. This trend for 
collagen III vs. I has also been confirmed by using a time-domain system. Elastin was distinct 
from type III collagen, p=0.0002, and measured the longest average lifetime of ECM proteins 
in this study, with a value of 6.78 ns. 
 
Table 2. Single exponential fitting for fluorescence samples 




 fractional intensities  
average 
lifetime (ns)  
τ1 τ2  α1 α2  f1 f2  τavg  
FAD 2.57±0.02 -  1 -  1 -  2.57±0.02  
FITC 3.94±0.05 -  1 -  1 -  3.94±0.05  
9CA 11.75±0.02 -  1 -  1 -  11.75±0.02  
 
Table 3. Multi-exponential fitting for protein samples 








τ1 τ2 α1 α2 f1 f2 τavg 
col1 6.77±0.24 0.84±0.04 0.121 0.879 0.525 0.475 3.95±0.13 
col3 7.46±0.24 0.76±0.09 0.150 0.850 0.633 0.367 5.01±0.22 




Table 4. Multi-exponential fitting for ocular tissue samples 








τ1 τ2 α1 α2 f1 f2 τavg 
cornea 8.44±0.82 0.22±0.05 0.024 0.976 0.486 0.514 4.27±0.84 
sclera 9.53±0.25 1.03±0.09 0.254 0.746 0.759 0.241 7.48±0.23 
 
Table 5. Multi-exponential fitting for wound skin samples 








τ1 τ2 α1 α2 f1 f2 τavg 
skin 13.08±0.80 0.72±0.14 0.049 0.951 0.484 0.516 6.72±0.24 
wound 18.98±0.42 1.15±0.32 0.052 0.948 0.475 0.525 9.74±0.96 
 
A two-exponential fitting was used for the tissue samples, follow by the calculation of τavg. 
For the ocular tissues, cornea measurements showed much shorter average lifetimes of 4.27 ns 
than sclera at 7.48 ns. For the murine skin tissues, the 8 mm murine skin wound at 14 days 
post-wounding showed a distinct, longer average lifetime at 9.74 ns versus normal skin at 6.72 
ns. This is attributed to the bias of collagen III fibers (with longer lifetimes) laid down during 
the wound healing process. Murine wounds models used in this study have been reported [1] 
to express high level of type III collagen around 10-17 days post wounding, coinciding with 
the day 14 sample in the present study. It should be noted that tissue autofluorescence is 
comprised of numerous potential fluorophores other than collagen and elastin. The two-
exponential fitting, while adequately describing the tissue measurements in this manuscript, 
could be improved by the addition of spectral-lifetime discrimination, as discussed in the 
Future Modifications section. 
 
Performance of FD ECM Detection System 
To provide a comparison of the temporal resolution and the sensitivity of the FD ECM 
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detection system, Figure 7 shows the standard deviations of repeat lifetime measurements of 
different sample amounts (collagen I mass and FAD concentration), which correspond to a 
range of emission intensities (Power). At lower mass/concentrations, FD lifetime 
measurements remain the same, but include greater standard deviations. A limit of 5% relative 
standard deviation was used, i.e. ~20 times signal to error ratio, as a cut-off for the limit of 
detection (LOD) determination. The sensitivity results showed that the system has a LOD of 
25 µg for type I collagen and a LOD of 1 µM for FAD detections, while maintaining below 5% 
relative standard deviation. At both collagen and FAD LODs, the detected optical power was 






Figure 7. FD ECM detection system sensitivity. A) Limit of detection of solid samples was 
characterized by using collagen I detections at various masses, with the resultant time 
resolutions (in ns) and relative standard deviations plotted against power and mass. B) Limit 
of detection of liquid samples was characterized by using FAD detection at various 
concentrations, with the resultant time resolution and relative standard deviations plotted 
against power and concentration. 
 
With respect to skin tissue detections, the probe illuminated a spot size of 5 mm, with 
penetration depth below ~300 µm (365 nm light). This geometry is equivalent to an excitation 
volume of 6 µL. Considering skin collagen composition to be ~70% by weight [30], in vivo 
measurements would involve ~4.1 mg of collagen using the probe. Therefore, FD ECM 
detection system provides two orders of magnitude finer sensitivity (25 µg vs. 4.1 mg) with 
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200 picosecond temporal resolution than required for tissue detection, adequate for resolving 
type I versus type III collagen in the skin. 
 
Future Modifications for Complex Tissue ECM Collagens 
Although the focus of the detection here is types I and III collagen, ECM compositions of tissue 
can involve a number of additional collagen types. In ocular tissue, fibrils are primarily 
composed of type I collagen, although types III, IV, V, VI, VIII, XII and XIII have also been 
identified to a lesser extent [25, 8]. In skin, collagen IV and VII are associated with basement 
membrane and dermoepidermal junctions. In addition to multiple collagen types, other ECM 
proteins like elastin and fibronectin create a complex detection mixture. First, future 
modification of the described detection system will include focusing on the frequency band of 
40-50 MHz, which simplifies data acquisition and analysis without sacrificing collagen and 
elastin differentiation, as shown by the results given here. Next, instead of integrating all 
intensities above 400 nm, the emission can be divided into 400-450 nm, 450-500 nm, and 500-
550 nm spectral bands using a simple filter wheel setup. These bands may reveal additional 
biases towards lifetimes of different collagen types and elastin. This should provide improved 
discrimination in a combined spectral-lifetime technique, as reported by others [31, 32], while 
still maintaining the simplicity of the LED-based FD ECM detection. Lastly, the 
multiexponential model could be adapted to predict the fractional contents of major 
fluorophores. For example, a four-exponential model with lifetimes of collagen I, III, elastin 
defined a priori, and a final residual exponential to account minor fluorophores, can be used to 
calculate the relative quantity of each defined protein. These future modifications should 
improve the discrimination of tissue autofluorescence and provide additional quantitative 





A low cost, low complexity, LED-based FD ECM detection system has been described and 
shown to be capable of measuring distinct lifetimes for type I and type III collagens and elastin. 
Fluorescence lifetimes of ECM proteins collagen I, III, and elastin were quantified with 0.2 ns 
resolution using the low-cost frequency domain method, to compare with the majority of time 
domain ECM measurements in the literature. The phase shift and modulation of the LED light 
source were calibrated at each scan frequency for both aqueous and solid samples. ECM protein 
samples were fitted to a two-exponential model, with type I collagen having shorter average 
lifetimes at 3.95 ns while type III at a longer 5.01 ns, distinct from the elastin lifetime at 6.78 
ns. The probe was tested on bovine ocular tissues, with cornea showing much shorter average 
lifetimes of 4.27 ns than sclera at 7.48 ns. Furthermore, measurements of 8 mm murine skin 
wound at 14 days post-wounding also showed distinct, longer average lifetimes at 9.74 ns 
versus normal skin at 6.72 ns. Finally, the sensitivity results showed two orders of magnitude 
lower detection limits than typical tissue and skin collagen compositions, with 200 picosecond 
lifetime resolutions. Future modification of the FD collagen system will focus on the 40-50 
MHz frequency range while separating the emission into three wavelength bands, providing 
additional spectral-lifetime discriminations. This work specifically targets and optimizes 
frequency domain lifetime detection of collagen variants in tissue, via a compact, easy-to-use 
package aimed at enabling clinical wound monitoring, tissue biomechanics monitoring, and 
other non-invasive biomedical applications. These results and the technique provide additional 
data points for collagen lifetimes in tissues, and further encourage clinical and interdisciplinary 
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Chapter 3 3D Printed Miniaturized Spectral System 
for Collagen Fluorescence Lifetime Measurements 
 
Introduction 
Collagen spectral lifetime 
Autofluorescence from collagen is commonly observed in fluorescence microscopy. The 
primary fluorophores contributing to collagen’s fluorescence are pyridinium, tyrosine, and 
phenylalanine groups [7-10], which can be affected by crosslinking, glycation, and their 
compositions in different types of collagens [11-13]. The effects of these multiple fluorophores 
can be seen in the lifetime of the collagen fluorescence, with evidence that lifetimes also vary 
across the emission spectrum [14-16]. Spectral-lifetime detection, then, can help distinguish 
the compositions of collagen types in a mixed environment like tissue or the skin. A simplified 
model of spectral-lifetime fluorescence can be described by  
I(λ, 𝑡) = 𝛼@(λ)𝑒%B/CD@F&               (1) 
Where the values of αi (λ) represent the relative contribution of the ith fluorophore at wavelength 
λ. The frequency response is typically measured at several wavelengths resulting in 
wavelength-dependent phase angle and the modulation values [17]. 
 
We observed that under the same illumination, collagens have varying fluorescence lifetimes 
corresponding to different wavelength bands [3]. We hypothesize that under these conditions, 
there will be certain wavelength bands that augment the fluorescence lifetime separation of 
different collagens. To investigate this possibility, we divided the fluorescence emission into 
three channels using three dichroics at 387 nm, 409, and 435 nm. For wound healing 
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applications, tissue collagen composition changes from type III to type I. The aforementioned 
bands cover the peak, shoulder, and tail portion of the collagen autofluorescence.  
 
Optomechanics rapid prototyping via additive manufacturing 
Additive manufacturing has been widely popularized for rapid prototyping in recent works, 
including 3D printed optical systems. Despite the limited spatial resolution and plastic built 
material in current commercial printers, there are already efforts in testing and characterizing 
3D printing for optical systems and optomechanical components [18]. Other optics and 
photonics applications include structured 3D phantoms [19], optofluidics [20], as well as 
miniaturized microscopy [21], in addition to numerous bioengineering applications. However, 
a high resolution printer is necessary in our microoptics design, where half inch optics need to 
be precisely aligned in a miniaturized setup. A 1º change in the dichoric orientation, for 
example, would incur a focal change on the order of 400 µm, which is a significant portion of 
the 1.5 mm diameter photodiode used in this microoptic system. To address this, a DLP (digital 
light processing) based lithography 3D printer with 43 µm resolution is employed to prototype 
the microoptics. DLP lithography is a 3D printing method that uses an ultraviolet light to photo-
crosslink a liquid polymer substrate [22]. Models built with CAD drawing program can be 
easily inserted into the software for the 3D printer. This compact professional printer can give 
us 585 dpi print resolution, or 43 µm resolution, with a layer thickness of 30 µm. Unlike 
extrusion based method where models are printed line by line, DLP 3D printing is imaged layer 
by layer, and the resolution does not affect the print speed. Only several hours of printing, 
without machining, are required to prototype our device with complex internal structure within 





Motivated by the benefits and limitation of novel non-invasive techniques, we designed a 
compact, low-cost optical system based on frequency domain fluorescence lifetimes to measure 
tissue collagen, Figure 8. Three-dimensional (3D) printing was employed to prototype such 
miniature optical systems, while the optical components including dichroic, lenses, and filters 
were selected with a diameter of 0.5”, creating an overall cylindrical device dimension of 
approximately 1.5” by 3”. Thermal and mechanical characteristics of the 3D printed 
optomechanics were analyzed using finite element analysis (FEA) and found to have minimal 
effects on ray tracing. Sine-modulated excitation and spectrally separated frequency domain 
emissions were then digitized and analyzed in MATLAB to calculate their lifetimes. Our 
results showed that such compact, spectral-lifetime detection system balances the portability 




Figure 8. Schematics of the 3D printed probe for tissue collagen differentiation. A) The 
prototype system is comprised of the microoptics sytem, LED, photodiode, driver electronics, 
USB oscilloscope, and a tablet for data analysis. It is designed to measure tissue collagen 
compositions via frequency domain fluorescence detections. B) A 3”x1.5” prototype 
microoptics mount was enabled by C) 3D stereolithogrpahy printing with <50 µm resolution. 
D) By leveraging both spectral and lifetime spectroscopy, the prototype can provide better 






The system was based on free space optics with a common optical path for the excitation and 
the emission intensities to optimize coupling and increase signal, Figure 9. It achieved spectral 
lifetime measurements by breaking up incoming intensity into three different bands via a series 
of longpass dichroics. Specifically, the bands were separated by longpass dichorics at 387 nm, 
409 nm and 435 nm. The first two bands, referred to here on as the 400 and 420 nm bands at 
their center wavelengths, correlated to the fluorescence emission profiles of collagens I and III. 
Wavelength above 435 nm, referred to here on as >435 nm band, can help to remove non-
collagen backgrounds.  
 
First, the modulated LED light source was filtered by a 357 nm, 44 nm bandpass filter and 
collected by an aspherical condenser lens to couple light towards the top surface of the first 
dichroic (387 nm, longpass). The 357 nm light was then reflected by dichroic, towards the lens 
at the sample. This excitation was illuminated on a fluorescence sample at a fixed geometry 
dictated by the 3D printed cavity and the lens’ focal length. The resultant emission and 
scattering were collected reversely through the same lens geometry, and filtered through the 
same dichroic, removing non-fluorescent scattering below 387 nm. Similar to aforementioned 
LED/first dichroic stage, the emission light was directed onto two other dichroics at the 
prescribed longpass wavelengths. Each of the subsequent three wavelength bands was then 
focused by an aspherical condenser lens onto a fast, PIN photodiode. The complete list of 




Figure 9. Spectral lifetime microoptics system setup. Three 45° longpass dichorics at 387, 
409, and 435 nm separate the system into four stages. All lenses were designed as f 4.2 mm 
condenser lenses to simplify the design. The first stage filters and collimates the 357 nm LED 
light onto the dichroic and subsequently focuses it on a fluorescence sample, e.g. skin, at a 
fixed geometry described by the lens’ focal length and a cavity within the 3D printed mount. 
Emission and scattering are collected through the same exact optical axis to maximize coupling, 
while the 387 nm dichroic removes the scattering intensities.  
 
Table 6. Component list of the system 
Components Type Part Specfications Diameter Volt 
Price 
($) 
Sample Optical Coupling 
Lenses Condenser ACL108 f 4.2 mm 10 mm  16.8 
Excitation 
Optoelectronics LED Digikey 537-1092 λ 365 nm 
f 4.2 mm 
λ 357 nm 
λ 387 nm 
4.4 mm 4.1V 35.75 
Lenses Condenser ACL108 10 mm  16.8 
Filter Band pass Edmund 86-973 12.5 mm 
 180 
Dichroic Longpass Chroma T387lp 12.5 mm 
 300 
400 nm Band 
Optoelectronics Photodiode Thor FDS025 λ 400-1100 nm 
f 4.2 mm 
λ 409 nm 
5.4 mm 20V 30 
Lenses Condenser ACL108 10 mm  16.8 
Dichroic Longpass Edmund 86-309 12.5 mm 
 140 
420 nm Band 
Optoelectronics Photodiode Thor FDS025 λ 400-1100 nm 
f 4.2 mm 
λ 435 nm 
5.4 mm 20V 30 
Lenses Condenser ACL108 10 mm  16.8 
Dichroic Longpass Edmund 87-051 12.5 mm 
 140 
>435 nm Band 
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Optoelectronics Photodiode Thor FDS025 λ 400-1100 nm 
f 4.2 mm 
5.4 mm 20V 30 
Lenses Condenser ACL108 10 mm  16.8 
Digitization       
Computer Tablet Dell Venue 8 Pro Matlab 
200 MHz 
8” 5V 250 
Oscilloscope USB Virtins 2820R  5V 250 
 
Custom built optomechanics 
To house the optical system, a tube was designed as two halves split down the center of its 
vertical orientation, with several joints added on to provide the mating surface, Figure 10A. 
The three dichroics dividing the system into four stages were designed with minimal distance 
from each other, allowing several millimeters for LED, heatsink, PIN photodiode alignment 
and mounting only. The shorter component distances, common axis, and free space design of 
the microoptics system ensures minimal coupling loss in a miniaturized package. 
 
 
Figure 10. 3D optomechanics system and FEA parameters. A) The grey components 
represent the optical tube mounts and LED/photodiode adapters that were 3d printed. The blue 
and gold colored filters represent the ½” longpass dichroics at prescribed wavelengths. The 
transparent orange shapes are 10 mm condenser lenses to provide the focusing and collimation 
for each stage. The overall dimension of the tube, not including the adapters, is around 1.5” x 
3”. B) Device thickness was varied in simulation. C) Mechanical loading on device was 
modeled after normal gripping (162 N) and adequate contact on sample/skin (25 N). 
 
The coupling of the system can be interpreted by the optical power measured at various stages 
in the microoptics system. A cellulose-based paper business card, was used for coupling 
measurements due to its similarity in excitation/emission wavelengths as collagen and its 
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strong fluorescence, Table 7. The power of the LED module going into the optics and the 
resultant power at the sample plane were measured as I0 and Icoupled, respectively, for the 
excitation stage. The resultant fluorescence from the paper was then measured with a calibrated 
spectrometer at their appropriate wavelengths. The Icoupled for each of those bands are then 
measured after the appropriate dichroics and lenses, at their respective photodiode positions. 
 
Table 7. Measured coupling at different stages of the microoptics system 
Stages I0 (𝛍𝐖) ICoupled (𝛍𝐖) 




 400 nm 0.16 0.06 
420 nm 0.12 0.05 
>430 nm 0.11 0.90 
*Paper as a fluorescent sample, 350 mA amplitude LED excitation. 
 
Thermal and mechanical FEA  
The design of the 3D printed optomechanic system was evaluated by both thermal and 
mechanical analyses using a 3D CAD model of the device and FEA. Initially, a 3D model of 
the microoptics system was constructed in CAD software (Inventor, Autodesk Inc.). The model 
was then discretized into a mesh geometry that was constrained and joined by nodes. The mesh 
model was then applied in the thermal and mechanical analyses with appropriate governing 
equations. Three-dimensional thermal strain was computed by specifying the thermal 
properties of the material (such as specific heat, thermal conductivity, etc.) and applied 
conditions (such as heat flux, temperature boundary conditions, etc.). In addition to stress and 
strain, the 3D temperature distribution was also obtained. FEA for both transient thermal and 
steady state thermal analyses were conducted using ANSYS. Similar to the thermal analysis, 
external mechanical loads from device handling were applied to the discretized finite element 
mesh in combination with defined material properties, to allow for numerical determination of 
strain at each elemental node and the stresses within each element. The deformations 
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subsequent to both thermal and applied mechanical loading were determined for several 
combinations of structural and material considerations.  
 
FEA parameters investigated 
The primary heating load for the device came from the LED that generated the incident light 
prior to contacting the tissue. The LED was obtained from Digikey (537-1092-1-ND) capable 
of 1 A current at 4.1 V. Based on our system coupling characterizations and typical tissue 
fluorescence emission, Table 7, we designed the LED with a maximum modulation of 200 mA 
to maintain photodiode intensities around a fraction of µW. Since current LED efficiency 
peaked at 40 % especially for blue wavelengths [22, 23], the joule heating was estimated at 0.5 
W. Thus the analysis was carried out by applying a heating load of 0.5 W to all surfaces directly 
exposed to the LED. Various structural thicknesses were investigated using this thermal 
modeling, Figure 10B. 
 
Contrary to the single thermal load, the detection system was subject to multiple mechanical 
loads. The device is to be held by a clinician, which is translated into two forces applied 
perpendicularly to both sides of the device. Based on studies of hand-held device in “Key Pinch” 
positions [24], right handed males at 20-24 years of age had an average key pinch strength of 
36.5 lbf or 162 N (90th percentile of this demographic). Thus, we simulated a load of 162 N to 
both sides of the device, Figure 10C. Additionally, the device was designed to come into 
contact with the patient’s body during normal operation. Therefore, it was assumed that the 
frontal load on the device would be no more than 15 % of the gripping strength, or 25 N applied 
at the front of the device, Figure 10C. Various thicknesses were investigated using this 




Our stereolithography technique is limited by its print material, unlike the array of available 
plastics in extrusion based 3D printing techniques. To investigate whether material choice is a 
factor in our printed geometry, we simulated the structure using three different materials—
VisiJet® FTX Green, Polylactic Acid (PLA) and Acrylonitrile Butadiene Styrene (ABS). 
VisiJet is the material used in our stereolithography printer, while PLA and ABS are available 
in extrusion based 3D printers. Along with the variation of the material type, four wall 
thicknesses—2.54 mm, 3.175 mm, 3.81 mm, and 4.45 mm (0.1”, 0.125”, 1.5”, & 1.75”)—were 
also investigated to determine the optimal dimension for each material.  
 
Optical ray tracing 
Ray tracing program TracePro (Lambda Research) was used to model the light propagation in 
the device and demonstrate the feasibility of optical system. This was done on a geometry with 
the optimal wall thickness as characterized from the thermal and mechanical FEAs. Due to the 
common path of the fluorescence excitation and emission employed in this design, the ray 
tracing was broken into two parts—excitation and emission geometries. Only the geometric 
optics without scattering or multiple reflections were modeled. Four wavelengths—one 
excitation and three for each emission bands—were simulated separately in the ray tracing. 
The positions of the optics and the optimal material thickness from FEA were adjusted to 
optimize the ray tracing towards the smallest spot sizes to ensure maximum coupling.   
 
Frequency domain method 
The prototype was applied to the detection of collagen I and III samples (dried fiber from 
bovine origin obtained from Sigma Aldrich, catalogue numbers C9879-1G and CC078 for type 
I and III, respectively). During data acquisition, the raw emission signals from the photodiodes 
were digitized by the USB oscilloscope. To remove nonlinear DC offsets from different scaling 
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and frequencies of the raw signals, offsets from dark readings (LED turned off) at specific 
measurement conditions were subtracted from the raw data before fitting and data processing. 
This process allowed more accurate calculations of the phase shift angles and modulation 
depths, without peak uncertainties, amplitude drifts, and waveform asymmetries from one part 
of the raw data to another. Raw data of 2x104 points were acquired by the oscilloscope, 
segmented into 1250 points strings, and averaged together to provide a working data length. 
This self-averaging allowed for faster data acquisition while averaging over data jitters. FFT 
was done on this data length to extract the phase and modulation components at the particular 
frequency that was scanned. Frequencies at 10, 20, 30, 40, 50, and 60 MHz were scanned, and 
ten sets of frequency scans were done for each sample being measured. All of the data 
acquisition and signal analysis were done within Matlab (Mathworks, Inc.) with vendor 
supplied hardware drivers. 
 
After calculating the phase angles and modulation depth ratios between 10 MHz and 60 MHz, 
the data was fitted to a multi-exponential model [6, 25], where the fluorescence impulse 
response function was described in equation (1). Thus, the fractional intensity observed in the 
usual steady-state measurement due to each component in the multi-exponential decay [17] is 
𝑓 = WDCD
Wh hCh
            (4) 
Where 𝑓@ = 1. Lifetime can be finally calculated by 
τ = 𝑓@𝜏@                              (5) 
 
Electronics and data acquisition 
The optoelectronics and data acquisition of the system were designed to achieve optimal 
portability. A custom LED driver circuit and switchable photodiode transimpedance amplifier 
were initially designed for the microoptics system. However, both prototype boards were too 
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large at 1”x3” dimensions and not suitable for integration. Therefore, the biophotonics results 
were finally obtained by guiding an LED source modulated at 10-60 MHz (Thorlabs DC3100-
365) to the microoptics system via a 0.22 NA 600 µm UV solarized fiber cable (Stellarnet). 
Similarly, the emissions after each dichroic were manually guided to an avalanche photodiode 
(Thorlabs APD120A2) with 2.5 x 106 V/W gain via 600 µm fiberoptics.  
 
Digitization of both the LED trigger signal and photodiode signal was provided by USB DSO 
(Virtins DSO-2820R). 2x104 sample data at 2 GS/s were acquired within the DSO’s software. 
Raw data were imported into Matlab for FFT analysis and calculation of the fitted two 
exponential decay models as described earlier. All computer controls were performed on a Dell 
Venue 8 Pro tablet running Windows 10. The entire portable package, include the computing 
unit, battery, and microoptics, weighed less than 4 pounds and can fit in a small suitcase, Figure 
8.  
 
Result and discussion 
Thermal and mechanical FEA were conducted before the devices was printed. Both models 
showed negligible deformations which did not lead to loss of optical performance. The 
geometry was further optimized with ray tracing to form the final 3D printed structure. After 
calibration of the devices, lifetimes of type I and III collagen in the three wavelength bands 
were measured and calculated. 
 
Thermal FEA results indicate negligible strain 
As stated earlier, the thermal analysis was carried out with the assumption that all surfaces 
exposed to the LED underwent a heat flow of 0.5 W. All temperature gradients were localized 
near the LED emitter, as the plastic material are expected to have low thermal conductivity. A 
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temperature probe was placed on the cylinder surface below the LED emitter and its readings 
were plotted for the different materials in Figure 11A. During our modeling, temperature 
distributions remained within 2.54 mm of the wall thickness. Thus, thermal analyses were only 
carried out at a wall thickness of 2.54 mm for each material.  
 
A clear difference in the materials’ response to the heating load can be observed. Over a period 
of 60 seconds, VisiJet® FTX Green was clearly the superior choice in terms of heat dissipation. 
Furthermore, ABS was the most inferior material with respect to thermal performance, 
reaching a temperature over 110°C after 60s. The device is expected to be operated in short 
measurement durations, e.g. several seconds each for the three channels and dark noise 
readings, totaling up to ten second or so of continuous operation. At these conditions, the PLA 
and VisiJet temperatures stayed below the typical scalding temperatures for contact, which 
would be reached at 60°C after 20s. Thus, by considering only the thermal characteristics, it is 
evident that PLA and VisiJet® FTX Green were comparable options for the device’s structural 
material. It should be noted that all materials showed negligible thermal strain for their 
respective maximum temperatures reached. Therefore, the thermal characteristics of various 
materials was only considered from an operator’s safety and comfort perspective rather than 
the functional optomechanics perspective. 
 
Mechanical FEA results are comparable to other 3D printings 
On the other hand, the device was subject to the mechanical loading conditions described in 
the FEA parameters section. The device experienced deformation along multiple axes during 
the simulation. However, only the deformation that occurred normal to the main optical axis 
of device appeared to be significant. Deformation along other axes of the device were minute 
and evenly distributed, so any lateral distortions to the optical mounts and dichroic were 
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negligible. To compare the various materials, the maximum interior deformations of the device 
were plotted for various wall thicknesses in Figure 11B. All three materials observed the same 
amount of deformation for wall thicknesses of 2.54 mm and 3.175 mm. When the wall 
thickness increased beyond 3.175 mm, a noticeable difference across the various materials 
occurred. Notably, all materials had deformation that leveled out at thickness above 3.81 mm. 
Based on lowest stress-strain curve, PLA was the ideal choice for the structural components, 
followed by ABS and then VisiJet® FTX Green. In addition, 3.81 mm was the optimal 
thickness for PLA and ABS, while no improvements were observed for VisiJet with thickness 
above 3.175 mm for the designed optomechanics geometry. Post FEA, all subsequent designs 
and builds using our Projet 1200 stereolithography printer adopted a 3.175 mm thickness. 
 
 
Figure 11. Thermal and mechanical FEA for wall thickness and materials in 3D printing. 
To compare the materials between stereolithography and extrusion based 3D printing, ABS, 
PLA, and VisiJet Green (3D Systems) were investigated for thermal distribution and 
mechanical deformation in the designed geometry. A) Temperature gradient localized around 
the LED emitter showed that ABS developed higher temperatures than PLA or VisiJet Green. 
Temperature measured in VisiJet material remained below 60°C after 20s of typical LED 
operation. B) Maximum deformation inside the microoptics housing is plotted at different wall 
thicknesses for the three printing materials. All materials have similar deformations below 
3.175 mm, while ABS maintains the lowest deformation at higher wall thicknesses. 
 
Ray tracing for optical optimization 
At the optimal wall thickness modeled in the thermal and structural analyses of the photonic 
reader device, there was no observable effects upon the ray tracing performance of the device. 
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The deformations of the housing and the subsequent relative motions of the optical components 
still resulted in appropriate optical quality and performance, as simulated through the optical 
ray tracing. Furthermore, to ensure minimal coupling losses, the distances between parts were 
optimized to produce ray tracing with the smallest spot sizes.  
 
Ray tracing of the excitation stage was modeled separately from the rest of the system to 
simplify the common axis for fluorescence in the optomechanical design, Figure 12A. 365 nm 
light from the LED passed through an excitation filter and a condenser lens, reflected from a 
45 ° dichroic, and was focused on a sample through a second condenser lens. Due to the finite 
size of the LED emitter (2.3 mm), its image at the sample was adjusted relative to the focal 
length of the condenser lens in order to achieve a focused spot of 2.6 mm, Figure 12B.  
Next, the emission stages corresponding to the three detection bands were modeled in ray 
tracing using 400 nm, 420 nm, and 435 nm wavelengths, Figure 13A. The resultant intensity 
showed spot sizes of 1.8, 1.5, and 1.5 mm diameters at the detector planes of the 400 nm, 420 
nm, and >435 nm stages, respectively, Figure 13B. After the ray tracing analysis, the CAD 
design was updated for 3D printing. The final 3D printed geometry represented the optimized 
structure that provided the smallest spot size via ray tracing. 
 
 
Figure 12. Optical ray tracing simulation of the excitation stage. Excitation ray tracing is 
simulated from the LED source through filter, lenses, dicroic, and finally the sample. A) profile 
view of the ray tracing for the excitation stage. B) Total irradiance map on the surface of sample. 
The light spot is around 2.6 mm by 2.6 mm, which is close to the size of LED light source of 





Figure 13. Optical ray tracing simulation of the emission stages. Emission ray tracing is 
simulated from the sample, through the optical system and to target photodiodes for each 
detection band. A) profile of ray tracing with the diameter of fluorescence light source at 2.6 
mm. B), C) and D) represent the total radiance on photodiodes, which have size of 1.8, 1.5, and 
1.5 mm, respectively. The circles provide references to the actual photodiode sensor area. 
 
Frequency domain phase shift results 
For both collagen samples measured, the phase shift angles rose with increasing frequency with 
an inverse tangent profile, Figure 14A, B, consistent with equation (2). Higher phase shift 
denotes to longer lifetime at a particular frequency. Upon closer examination of the differences 
between the three channels, the first channel always resulted in the lowest phase shift. At higher 
frequencies, 420 nm band phase shift rose above that of the >435 nm band for collagen I, but 
the two bands overlapped across frequencies for collagen type III.   
 
Frequency domain demodulation results 
For both collagen samples measured, the modulation depth ratios decreased with increasing 
frequency following a decay profile, Figure 14C, D, which was consistent with equation (3). 
At a particular frequency, deeper demodulation generally denotes longer lifetime. As a trend, 
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collagen I had shallower demodulation than collagen III. Specifically, modulation depth ratios 
showed more separation between 400 nm and 435 nm bands, as the measurements showed 
consistent, smaller standard deviations. 
 
Frequency domain lifetime 
To differentiate the lifetimes of type I versus type III collagen for the three spectral channels, 
phase and demodulation data were fitted in a two-exponential decay model and tabulated in 
Table 3. In the table, τφ is the phase shift lifetime, τm is the demodulation lifetime, and τ is the 
apparent lifetime. Apparent lifetimes were calculated using a minimization function that 
weighed both phase and demodulation data according to their standard deviations. Spectral 
lifetime results in Table 8, which ranged between 2-4 ns for type I and 3-5 ns for type III, 




Figure 14. Frequency domain results for spectral-fluorescence separation of collagen I/III. 
Collagen I results are shown in the left hand column (A and C), while collagen III results are 
shown in the right (B and D). For both the phase (top row) and modulation (bottom row) graphs, 
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the 400 nm, 420 nm, and >435 nm bands are plotted as blue, green, and red, respectively. 400 
nm bands showed phase and modulation results consistent with shorter lifetimes for both types 
of collagen. Phase results for collagen I, A), are smaller than that of collagen III, B), but 
collagen III flattens out above 30 MHz. Similarly, modulation results for collagen I, C), are 
shallower than that of collagen III, D). Generally, bands for collagen type I are further separated, 
while collagen type III has more overlaps and crossovers.  
 
Table 8. Calculated lifetimes for collagen I and III at multiple bands 
Type  Lifetime  400 nm 420 nm >435 nm 
Col I 𝜏j(𝑛𝑠) 2.2767±0.0442 2.9151±0.0516 2.8211±0.0430 
𝜏,(𝑛𝑠) 3.0007±0.1769 3.8135±0.2552 4.4541±0.0955 
τ 𝑛𝑠 * 2.6484±0.0599 3.4559±0.1116 4.1087±0.1310 
Col III 𝜏j(𝑛𝑠) 2.3380±0.0926 2.7091±0.1024 2.9145±0.0544 
𝜏,(𝑛𝑠) 4.3116±0.3625 4.9300±0.1649 5.6041±0.1655 
τ(𝑛𝑠)* 3.2600±0.1462 4.8088±0.1954 5.3316±0.1626 
*Apparent lifetimes via two-exponential fitting. 
Time domain (TD) references provided for comparison. 
 
Lifetimes increased from 400 nm, to 420 nm and above 435 nm for both collagens. Collagen 
III had longer lifetime than collagen I. In our results, both spectral intensities and lifetimes 
contribute to the separation of the collagen I versus III. 400 nm band had higher signal 
intensities in general, but smaller lifetime differences between the collagen types, while 420 
nm band had lower signal intensities but greater lifetime differences. In the application of 
wound healing monitoring, where closed wound undergoes collagen remodeling from type III 
to type I collagen [1, 2], the emission intensity will be reduced, and 400 nm band should provide 
an important measurement due to its higher intensity. However, 420 nm band should provide 
a better lifetime contrast despite its lower intensity. By leveraging both channels for spectral-
lifetime detection, more precise differentiation, and thus accurate monitoring of tissue collagen 





Despite efforts to miniaturize the optomechanics structure, the prototype LED driver and 
photodiode transimpedance amplifier circuitry still required significant space. Additional 
embedded solutions are needed to provide further electronics integration. Moreover, data 
acquisition was done manually with DSO’s software and imported into Matlab. A simple 
graphical user interface should make system operation user-friendly and less prone to errors. 
Additional structural mechanics such as the handle housing and wiring have yet to be 
implemented as well. The low intensity in actual tissue applications may require the use of 
avalanche photodiodes, which require higher bias voltages. Finally, multiple excitation 
wavelengths may be possible in the same optical train by the use of multi-colored LED diodes, 
which may broaden the available tissue fluorophores to detect, e.g. nicotinamide adenine 
dinucleotide (NADH).  
 
The collagens used in this manuscript are purified fibrous proteins and intended as a proof of 
concept of the miniaturized probe. We have noticed different sources of proteins, e.g. skin, 
tendon, as well as different preparations and solutions greatly affect collagen autofluorescence 
lifetimes [5, 6, 27, 28]. An extensive tissue based study is necessary to provide confidence in 
the frequency-domain technique as a diagnostic tool, similar to efforts in time-domain studies 
[28]. In clinical applications, we envision the probe to be calibrated for individual patient’s 
baselines, for example a person’s normal skin versus healing wound. The relative differences 
of tissue collagens for that patient will then be the measurement instead of an absolute lifetime 
value, where the dynamics of the measurements over time provide diagnostic information 
rather than static snapshots.  
 
In this study, the miniature spectra-lifetime system was applied to the detection of type I versus 
III collagen, which are the major parameters of tissue remodeling in a closed wound. In the 
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future, such portable spectral-lifetime system can be applied to clinical detection of advanced 
glycation end-products in diabetic skin, tissue fibrosis and scarring in wounds, and 
collagen/elastin compositions in aging skin, among others.  
 
Summary 
A miniaturized optical system was designed for spectral-lifetime measurements of collagens I 
and III. The system was comprised of a small tablet and USB DSO, LED, photodiode elements, 
and a 3D printed optomechanic structure, well-suited to portable detection applications. 
Thermal and mechanical FEA demonstrated negligible deformations during expected operation 
and handling of the device. Ray tracing further optimized the 3D printed optomechanics 
structure. Type I and III collagen lifetimes were measured across three spectral bands with our 
device, and were distinguished from each other. We found that 400 nm band gave higher signal 
intensity while the 420 nm band provided greater lifetime differences between collagen I and 
III. In tissue applications where low autofluorescence is combined with minute differences in 
collagen composition, multiple spectral channels with lifetime measurements may allow better 
collagen detections than either one along. The 3D prototyped miniature system has the potential 
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Chapter 4 Enabling FLIM for Histology: Facile and 
Stain-free Tissue Lifetime Imaging 
 
Introduction 
Monitoring protein glycation in diabetes 
The wound healing process aims to repair damaged and open skin structures by depositing 
ECM proteins and changing their composition and crosslinking over time, a remodeling 
process that strengthens the tissue back to its normal biomechanical state [13-17]. Type I and 
III collagen, two key collagen forms in wound healing, have similar molecular structures, albeit 
thicker fiber bundles for type I collagen than type III. Type III collagen is deposited early in 
wound healing by fibroblast, and later remodeled and replaced by type I collagen, due to the 
stronger mechanical properties of its fibers [16, 17]. Based on our previous result, pure collagen 
III fibers exhibit longer lifetime than type I fibers (4 vs. 5 ns) [5, 6], which suggest that tissue 
lifetimes can be used to differentiate and monitor the process of wound healing.  
 
Moreover, wound collagens can be modified by diabetes through protein glycation [18-24]. 
Diabetes, characterized by hyperglycemia, results in chronic complications of the eye [25, 26], 
nervous tissue [27-29], kidney [30-32], wound ulcers [33-35], and pervasive damage to the 
body’s cardiovascular and peripheral vascular systems [36-39]. Specifically, elevated blood 
glucose increases protein glycation and leads to a gradual build-up of advanced glycation end-
products (AGEs) in tissue [39-42]. AGEs further induce ROS formation [38, 40, 41], resulting 
in oxidative damage, protein crosslinking, inflammation, and decreased cell proliferation [43-
47]. AGE related damage, in addition to an already poor microvasculature and impaired cell 
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recruitment [34, 35, 46, 48, 49], contributes to improper wound healing in diabetes. This is 
especially acute in body extremities like the foot, where the aforementioned problems are 
exacerbated by the lack of circulation, leading to non-healing wounds—e.g. diabetic foot ulcers. 
 
Incidentally, pentosidine—a major AGE species derived from collagen crosslinking [50-53]—
is also a prominent fluorophore with modified lifetime signature compared to collagen [52-53]. 
Therefore, lifetime measurements of ECM components of collagen I, III, elastin, and their 
modification by the addition of pentosidine can provide a set of standards for lifetime-based 
tissue histology. Furthermore, these measurements were extended to the imaging of a full-
thickness diabetic foot ulcer, demonstrating a label-free and disease-specific imaging modality 
that can complement standard collagen histology and immunohistochemistry. 
 
Method 
LED tissue lifetime imaging system 
We have previously demonstrated frequency domain based collagen detections [5], including 
a 3D printed microoptics system [6]. Here we extended the technique to an imaging modality 
for lifetime-based tissue histology. Moreover, we elected to use scanning imaging in lieu of 
wide-field imaging to avoid complicated gated imager. This enabled the realization of a 
compact, upright LED modulated scanning microscope, Fig. 1, with components costing less 
than $17k USD (Supplmentary Table 1). In this system, light from a 1 mm2 emitter (Thorlabs 
DC3100-365) is continuously modulated at 20 MHz and coupled into the microscope optical 
train via a 275-375 nm band pass filter and a 4X, 0.15 NA objective (Amscope). This light is 
redirected via a 400 nm dichroic to a 60X imaging objective and projected at the sample 
plane with a spot size of around 78 microns FWHM (full width at half max). The objective 
allows over 3 mm of working space for the sample to be scanned on a stage driven by x-y 
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linear stepper motors (Thorlabs KST101). The scanning is set at a constant speed (2.5 mm/s) 
and scans continuously in an S-shaped raster scan path, Fig. 1. The emission is imaged by the 
same 60X objective through the dichroic and filtered by a 400 nm emission filter before 
being focused onto an avalanche photodiode (Thorlabs APD120A2). Alternatively, a CCD 
camera can be placed between the filters and photodiode via a 45° mirror to allow visual 
focusing and spot size measurements. A digitizer (Picoscope 6404C) acquires data points 
from the photodiode with refresh rate of 28.9 Hz. Each acquisition point represents the 
emission lifetime of a 78 micron diameter spot on the sample.  
 
 
Figure 15. System schematic. The system including LED, objectives, filters and dichroic, 
digital camera, stepper motor and controller, digitizer, and computer in an up right designed 
for histological measurement of tissue. Using a raster scanning pattern, a 6 by 6 mm M logo 
(top left corner) printed on paper was imaged using the $17k USD system. 
 
System Characterization 
The final design of the microscope optics shown in Fig. 1 was realized via three system 
characterizations. First, the system was modeled by ray tracing (Trace Pro, Lambda Research) 
to understand the theoretical spot sizes of the excitation and emission intensities. Next, the 
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actual spot sizes were measured with various combinations of collection and imaging 
objectives. The results were plotted as a function of the etendues, or geometric extends, of the 
collection and imaging objectives. Objective combination yielding excitation spot with the 
appropriate intensity and FWHM size was selected. Finally, the data acquisition protocol was 
optimized for the best scanning speed at the selected spot size. 
 
Biophotonics Measurements 
Measurements using the LED tissue lifetime imaging system was demonstrated first by 
establishing a biophotonic model of diabetic skin wound, then by imaging a diabetic foot ulcer. 
For the diabetic wound model, fluorescence lifetimes of extra cellular matrix (ECM) proteins 
and their combination with AGE’s were measured. Purified fibrous Collagen I and III, and 
solid elastin powder were included as major ECM proteins (Sigma Aldrich). Pentosidine in 
PBS (Fisher BioReagents) was selected as the prominent autofluorescent AGE component in 
skin [52, 53]. Pentosidine was added to the ECM proteins at 7 µg/mg protein ratio according 
to reported in vivo skin compositions [52], and dried overnight for combined measurements. 
Next, a diabetic foot ulcer was imaged. This 3 cm by 3cm full thickness donor tissue (71 years 
old male, type I diabetes) was obtained from Tissue for Research Ltd, frozen in -80°C. The 
approximately 3 by 3 cm ulcer area was cut into 9 squares for imaging individually, and the 
combined frames were combined into a collage for display. 
 
Data acquisition and analysis 
All frequency domain modulation was applied at 20 MHz via the 365 nm LED (Thorlabs 
DC3100-365). Data acquisition was triggered via the LED output and recorded on an USB 
digitizer (Picoscope 6404C) at 1.25 GSps. Recorded data was averaged prior to the Fourier 
transform frequency analysis. To average the data, the data set was truncated into lengths of 
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1250 data points (which allows fundamental frequency to hit 20 MHz), each offset by 2π phase 
or one period apart. For example, a 10k data set will provide 140X averages of the 1250 point 
long data length. The averaged data was then Fourier transformed to analyze the magnitude 
and phase of the signal at 20 MHz compared. The demodulation and phase lifetimes are 
calculated using these FFT components and fitted to a multi-exponential model as described in 
our previous publications [5, 6]. Three lifetime measurements were recorded per image pixel 
per acquisition. 
 
Result and discussion 
Optical ray tracing 
Ray tracing was employed to model the theoretical excitation and emission spot sizes, Figure 
16. The system was separated into the excitation and emission paths. The image of the 
excitation spot at the sample plane, Figure 16A, was carried forward to the emission path to 
produce the spot at the detector plane, Figure 16B. The 4X-60X objective pair resulted in an 
excitation spot smaller than 100 µm and an emission spot that matches the 1 mm diameter of 





Figure 16. Ray tracing modeling. A) ray tracing of emission arm. 365 nm light from LED is 
collimated by 4x objective and reflected by 400 nm dichroic. Then the reflected collimated 
light goes through 60x objective (including aperture), and focuses on sample. B) ray tracing of 
excitation arm. Fluorescence collimated by 60x objective with wavelength over 400 nm pass 
through dichroic and 400 nm long pass filter to filter out reflection, focus on detector though 
lens. 
 
Etendue and spot size characterization 
The image of the excitation spot at the sample plane is a result of the reduction ratio between 
the collection and imaging objectives. Moreover, the amount of light coupled through these 
objectives ultimately affects the intensity of the resultant spot. this light coupling can be 
expressed in terms of the geometry extend, or etendue G: 
𝐺 = πS𝑁𝐴. 
Where S is the cross sectional area in mm2 and NA is the numerical aperture. To characterize 
the system, the optical power was plotted as a function of the etendue of each objective. For a 
fixed imaging objective, the optical power increases exponentially versus the collection 
objective’s etendue, Figure 17A. However, the etendue coefficient (ratio of imaging to 
collection etendue) shows a maximum versus the collection etendue, beyond which the 
throughput is limited by the imaging objective. For a fixed collection objective, the optical 
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power also increases exponentially with the imaging objective’s etendue, Figure 17B. Here, 
the rise of optical power is more sensitive to the imaging etendue than the collection etendue, 
consistent with the observation that throughput is limited by the imaging objective. 
 
To select the combination of objectives that produces a small and bright excitation spot, the 
maximum CCD count per integration time was plotted against the measured FWHM diameter, 
Figure 17C. Both intensity and etendue coefficient were optimized for spot sizes between 60-
80 µm. Finally, the objective combination of 4X and 60X was selected for maximum intensity 
with a spot size of 78 µm, Figure 17D. This spot size allowed us to scan at a conservative pixel 
resolution of 100 by 100 µm, used in all of the scanning results shown in subsequent data. 
 
 
Figure 17. Etendue and spot size characterization. A) Using the same imaging objective, 
normalized optical power increases exponentially while the etendue coefficient shows a 
maximum beyond which throughput is limited by the imaging objective. B) Using the same 
collection objective, both power and etendue coefficient increases exponentially as a function 
of the imaging objective’s etendue. C) The intensity and etendue coefficient were both 
optimized for a spot size between 60-80 µm. D) We selected a spot size of 78 µm produced by 





The imaging speed is limited by the scanning speed of the stage, which is dependent on the 
acquisition speed of the digitizer (Picoscope 6404C). Moreover, the digitizer’s speed of 
acquisition is inversely proportional to the chosen buffer size. Therefore, the buffer size was 
varied to examine its effect on the data acquisition rate and the resultant data quality (i.e. 
standard deviation) as shown in Figure 18. As expected, the larger the selected buffer size, the 
slower the acquisition rate (pixel per second). However, larger buffer size allows for more data 
averaging, which reduces the data noise in terms of standard deviation. As shown in Figure 18, 
standard deviation of the data increases sharply when buffer size is less than 10k, while the 
acquisition rate flattens out below the same 10k buffer size. Below 10k buffer size, data 
acquisition is limited by the time it takes the digitizer to turn on and off. To balance the 
scanning speed versus data quality, we choose 10k as our minimum buffer size for data 
acquisition. For a sample area of 5 mm by 5 mm at 100 µm resolution, the scanning would take 
approximately 15 minutes. Up to 1.4 cm by 1.4 cm area has been achieved here, for the diabetic 
ulcer imaging presented in subsequent results. 
 
 
Figure 18. Data acquisition rate and standard deviation versus buffer size. Buffer size is 
inversely related to data acquisition rate and standard deviation (a measure of data noise). 
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However, above 10k buffer the standard deviation does not appreciatively decrease while 
below 10k the scanning speed is limited by the digitizer’s on/off rate. Thus, 10k was selected 
to be the optimal buffer size used in all subsequent scanning. 
 
Biophotonic model of diabetic wound 
To understand the components of the diabetic wound, we applied the LED tissue lifetime 
imaging system to scan purified ECM and AGE (pentosidine) samples to characterize their 
individual and combined lifetimes, Figure 19. The lifetimes of pure ECM proteins were 
3.9±0.012, 4.2±0.049, and 6.3±0.081 ns for collagen I, III, and elastin, respectively, and 
agreed with our previous reported values [5, 6]. The pentosidine AGE by itself presented a 
lifetime of 3.2±0.61 ns. With AGE incubation, the ECM lifetimes were lowered to 3.7±0.21, 
4.0±0.25, and 5.6±0.17 ns, respectively. This measurement suggests that AGE in diabetic 
skin would lower the apparent lifetime values of both normal (predominant type I collagen) 
and wound (predominantly type III collagen) tissues. 
 
 
Figure 19. Intrinsic lifetimes of ECM proteins and their modification by pentosidine 
59 
 
(AGE). Collagen I, III, and elastin lifetimes were measured with and without the incubation of 
pentosidine as the major fluorescent advanced glycation end-product in the skin. Type III 
collagen lifetime was higher than type I both before and after the incubation. And the all ECM 
proteins + AGE combinations exhibited lowered lifetimes after incubation with AGE. 
Pentosidine in solution yielded the lowest measurable lifetimes while PBS has negligible 
fluorescence intensity. 
 
Imaging diabetic foot ulcer 
To enable stain-free imaging of the diabetic foot ulcer, 9 square areas were imaged individually 
and the resultant frames were combined to form a collage for presentation, Figure 20. The ring 
around the ulcer has low intensity, leading to noisy lifetime values. A threshold was applied to 
remove these values from display. Within this ring, the ulcer tissue displayed a higher lifetime 
of 4.4 ± 0.36 ns compared to a 3.72 ± 0.45 ns lifetime of the unwounded tissue outside, p<0.02. 
The longer lifetime is consistent with our previously reported trend between type III and type 
I collagens [5,6], indicating a non-healing wound, i.e. an ulcer. Moreover, it can be seen that 
the unwounded tissue has shorter lifetime than pure collagen I protein from Figure 19, with 
values closer to that of collagen I + AGE (3.6 vs. 3.7 ns). For reference, normal skin tissue has 
a measured lifetime of 3.9 ± 0.07 ns. This fits our model of AGE modified diabetic skin. 
However, the lifetime of the wound area is closer to that of unmodified collagen III protein 
(4.4 vs. 4.2 ns), suggesting that the ulcer in our sample may not be affected by AGE to the 
same degree as unwounded tissue. This result demonstrates the potential of the LED tissue 
lifetime imaging in discriminating diabetic wounds and ulcers using a biophotonic model 




Figure 20. LED tissue lifetime imaging of diabetic foot ulcer. A) A full thickness diabetic 
foot ulcer (3 by 3 cm) was obtained and cut into 9 squares (overlay) for label-free collagen 
imaging. B) The pseudo colored lifetime map shows that ulcer tissue has higher lifetime than 
surrounding unwounded tissue. Moreover, the unwounded tissue has lower lifetime than 
normal skin with predominantly type I collagen, suggesting that unwounded diabetic skin is 
more affected by pentosidine as an AGE than the ulcer tissue. 
 
Future Works 
In this work the scanning of a 1 cm by 1 cm sample area, similar size to a single histological 
section, takes roughly 40 minutes to complete. This should be taken into context of the staining 
and labeling protocols, e.g. picro Sirius stain and immunochemistry prep, which takes up to 
half a day to complete. However, to enable faster scanning, wide-field imaging has to be 
considered. Due to the lowered frequency and simple sinusoidal modulation, we plan to build 
simplified gating circuits with off-the-shelf ocular image intensifiers in front of CMOS sensors, 
rather than using the more complicated ICCD (intensified charged-coupled device) imagers for 
wide-field applications. Additionally, collagen imaging can be enhanced with the spectral-
lifetime techniques we previously developed for point detections [6]. Lastly, the electronic 
components can be consolidated into a single enclosure, with a GUI (graphical user interface) 
wrapped script to automate the microscopy and further simplify user operations. 
 
Summary 
A LED based tissue lifetime imaging system was constructed and automated for the detection 
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of ECM proteins and their modification by pentosidine in diabetic wounds. The system was 
capable of scanning large centimeter squared areas with 100 µm pixel resolution (78 µm 
FWHM spot size). Using this system, collagen I, III, and elastin proteins with and without 
pentosidine were measured, showing that their lifetimes were lowered by the AGE incubations. 
This is also observed in our diabetic foot ulcer imaging, where the normal skin shows greater 
lifetime suppression by AGE than the ulcer itself. Beyond wound healing and diabetes, a 
number of collagen and ECM related diseases can be imaged by our label-free microscopy—
scarring, tissue fibrosis, tumor demarcation, and tissue inflammation diseases. By providing a 
quantifiable, more nuance model of tissue biophotonics while dramatically lower the cost of 
instrumentation, the LED tissue lifetime system hopes to increase accessibility and popularity 
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Chapter 5 Conclusion 
 
There have been technical breakthroughs in tissue histology and collagen detection in the forms 
of FLIM, SHG (second harmonic generation), and collagen autofluorescence detection. 
However, these advancements did not break through the standard mold of tissue histology, and 
often times require the same, if not more, sample preparation through tissue labeling and 
immunohistochemistry. What this thesis has achieved is the development of a new frequency 
domain technique for tissue ECM discrimination, and the realization of a number of 
instrumentation that facility its applications as a point-of-care, benchtop, or imaging microcopy 
modality. Furthermore, the work has generated a body of published data on the intrinsic 
lifetimes of collagen I, III, elastin, and their pentosidine modified counterparts. This forms a 
necessary biophotonic model for the interpretation of raw, composite lifetimes measured from 
tissues. Furthermore, by creating the suite of easily accessible devices, these works broaden 
the appeal of the technique for numerous clinical and biomedical research laboratories that may 
have great interest, but do not desire the complicacies associated with traditional 
instrumentations. From these works, several key areas are identified that require future work. 
The electronics integration is a key component in the miniaturization and simplification of the 
instrumentation, important from a usability perspective for clinical researchers. Next the 
spectral and lifetime optimization gained from our work needs to be implemented in a 
automatic manner, through additional software and embedded programming. Lastly, a new 
method of gating wide-field imaging should be considered, for example using gating 
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intensifiers from night-vision gaggles. In addition to these future works, the hope is to continue 
the motivation behind this thesis towards further implementation and clinical applications of 
the frequency domain tissue lifetime technique. 
